Showing 1 results for
To top the agenda of pharmaceutical industry interests, the policy is designed to allow drug makers to raise the price of unscheduled formulations by up to 10% annually. Photo: Mint<br />

Drug pricing conundrum

4 min read . 03 Dec 2013
Edit Profile
My Reads Redeem a Gift Card Logout